Nuvation Bio Inc. NUVB
5.74
0.01
0.17%
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 0.0×
Follow NUVB
Insider Buys
alert about insiders buying in the last 12 month
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | — | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | — | 0.00 | 48.65 |
P/FCF ratio |
— | — | — | — | — | — | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | — | — | (15.44) | (102.92) |
P/B ratio |
— | — | — | — | — | — | 1.54 | 10.01 |
Price to Tangible BV |
— | — | — | — | — | — | 1.56 | 10.39 |
EV/Sales |
— | — | — | — | — | — | 0.00 | 41.08 |
EV/EBITDA |
— | — | — | — | — | — | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | — | (1.70) | (14.90) |
EV/FCF |
— | — | — | — | — | — | (1.69) | (14.87) |
Quick Ratio |
— | — | 33.10 | 45.40 | 50.41 | 44.00 | 8.91 | 6.67 |
Current Ratio |
— | — | 33.69 | 45.62 | 50.70 | 44.11 | 9.04 | 6.95 |
Net Debt/EBITDA |
— | — | 4.97 | 8.19 | 5.49 | 6.14 | 0.84 | 2.26 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.39% | 0.63% | 0.00% | 1.16% | 8.90% |
Debt/Equity |
— | — | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.17 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.11 |
Operating CF/Net income |
— | — | 0.88 | 0.79 | 0.92 | 0.90 | 0.23 | 0.85 |
Capex/Depreciation |
— | — | (1.41) | (1.53) | (1.79) | (0.25) | (0.24) | (3.48) |
Interest Coverage |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | — | (8.67%) | (18.07%) | (14.87%) | (12.03%) | (106.27%) | (53.18%) | |
| — | 0.00% | (37.57%) | (17.41%) | (14.39%) | (11.72%) | (97.74%) | (36.04%) | |
ROIC |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | — | (19.39%) | (11.49%) | (15.91%) | (12.57%) | (121.20%) | (41.77%) |
Average Days of Receivables |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 755.31 | 112.35 |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 1,258.97% | 182.99% |
Selling, General and Administrative Expense of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 879.37% | 240.95% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 409.95% | 57.06% |
Graham Net Nets |
— | — | — | — | — | — | 0.63 | 0.09 |
Graham Number |
— | — | — | — | — | — | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | — | (84.96%) | (6.70%) |
Free Cash Flow Yield |
— | — | — | — | — | — | (18.26%) | (5.68%) |
Revenue per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.18 |
Operating CF per Share |
— | — | (0.37) | (0.34) | (0.44) | (0.31) | (0.49) | (0.51) |
Capex per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.02) |
Free Cash Flow per Share |
— | — | (0.38) | (0.35) | (0.45) | (0.31) | (0.49) | (0.53) |
Cash per Share |
— | — | 2.21 | 3.87 | 3.05 | 2.79 | 1.87 | 1.55 |
Shareholders Equity per Share |
— | — | 2.21 | 3.77 | 3.02 | 2.76 | 1.73 | 0.90 |
Interest Debt per Share |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | — | 2.21 | 3.77 | 3.02 | 2.76 | 1.73 | 0.90 |
Free Cash Flow |
— | — | (36.67) | (68.47) | (96.46) | (68.05) | (130.57) | (181.78) |
Working Capital |
— | — | 214.13 | 755.15 | 654.16 | 602.46 | 468.01 | 489.29 |
Capital Expenditures |
— | — | (0.14) | (0.28) | (0.36) | (0.05) | (0.16) | (8.35) |
Net Current Asset Value |
— | — | 213.98 | 741.92 | 650.25 | 600.07 | 449.42 | 282.41 |
EV/EBIT |
— | — | — | — | — | — | 0.00 | 0.00 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.13 |
Net Profit Margin |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | (7,213.76%) | (325.31%) |
Price to Operating Income |
— | — | — | — | — | — | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | — | 0.15 | 0.23 | 0.22 | 0.31 | 1.17 | 4.26 |
Cash ROIC |
— | — | (8.64%) | (4.55%) | (7.35%) | (5.65%) | (13.47%) | (19.60%) |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.79 | 3.53 |
Accounts Payable Turnover |
— | — | 0.03 | 0.12 | 0.16 | 0.00 | 1.65 | 1.18 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Average Days of Payables |
— | — | 7,693.35 | 3,893.00 | 1,613.09 | 0.00 | 327.36 | 372.11 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 447.95 |
Average Receivables |
— | — | 2.07 | 2.07 | 2.76 | 3.09 | 10.00 | 17.83 |
Average Payables |
— | — | 3.05 | 3.05 | 3.03 | 2.17 | 4.28 | 7.91 |
Average Assets |
— | 0.00 | 110.90 | 498.97 | 724.15 | 646.81 | 581.06 | 567.72 |
Average Common Equity |
— | — | 480.54 | 480.54 | 700.54 | 630.10 | 534.46 | 384.75 |
Columns are period end dates